EP 3538129 A1 20190918 - A NEW FORMULATION FOR INTRANASAL ADMINISTRATION
Title (en)
A NEW FORMULATION FOR INTRANASAL ADMINISTRATION
Title (de)
NEUE FORMULIERUNG ZUR INTRANASALEN VERABREICHUNG
Title (fr)
NOUVELLE FORMULATION POUR ADMINISTRATION INTRANASALE
Publication
Application
Priority
- IT 201600112420 A 20161108
- IB 2017056945 W 20171107
Abstract (en)
[origin: WO2018087656A1] The present invention relates to pharmaceutical compositions comprising NGF or molecules with NGF-like activity for use in the treatment of traumatic brain injury by means of intranasal administration, a method for treating traumatic brain injury by means of intranasal administration of NGF or molecules with NGF-like activity, and an associated pharmaceutical kit.
IPC 8 full level
A61K 38/18 (2006.01); A61K 9/00 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 9/0043 (2013.01); A61K 38/185 (2013.01); A61K 47/02 (2013.01); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 2018087656A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018087656 A1 20180517; EP 3538129 A1 20190918; IT 201600112420 A1 20180508
DOCDB simple family (application)
IB 2017056945 W 20171107; EP 17809374 A 20171107; IT 201600112420 A 20161108